https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-16 / Genes Dis 2023 Mar;10(2):430-446
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-16 / Genes Dis 2023 Mar;10(2):430-4462021-12-16 00:00:002021-12-16 00:00:00Oncolytic viruses: A novel treatment strategy for breast cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-16 / Front Oncol 2021;11:789078
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-16 / Front Oncol 2021;11:7890782021-12-16 00:00:002021-12-16 00:00:00Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-29 / Cancers (Basel) 2021 Nov;13(23)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-29 / Cancers (Basel) 2021 Nov;13(23)2021-11-29 00:00:002021-11-29 00:00:00The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-08-20 / Front Immunol 2021;12:669965
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-08-20 / Front Immunol 2021;12:6699652021-08-20 00:00:002021-08-20 00:00:00Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-08-04 / Int J Mol Sci 2021 Aug;22(16)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-08-04 / Int J Mol Sci 2021 Aug;22(16)2021-08-04 00:00:002021-08-04 00:00:00Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer Models
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-08-01 / Anticancer Res 2021 Aug;41(8):4133-4141
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-08-01 / Anticancer Res 2021 Aug;41(8):4133-41412021-08-01 00:00:002021-08-01 00:00:00Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell Therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-07-01 / Anticancer Res 2021 Jul;41(7):3419-3427
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-07-01 / Anticancer Res 2021 Jul;41(7):3419-34272021-07-01 00:00:002023-03-07 11:15:55Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-05-19 / Mol Ther Oncolytics 2021 Sep;22:64-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-05-19 / Mol Ther Oncolytics 2021 Sep;22:64-712021-05-19 00:00:002021-05-19 00:00:00CD133 mRNA-transfected dendritic cells induce coordinated cytotoxic and helper T cell responses against breast cancer stem cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-04-06 / Cancers (Basel) 2021 Apr;13(7)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-04-06 / Cancers (Basel) 2021 Apr;13(7)2021-04-06 00:00:002021-04-06 00:00:00Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Mouse Breast Cancer Isografts
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-03-17 / Mol Clin Oncol 2021 May;14(5):103
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-03-17 / Mol Clin Oncol 2021 May;14(5):1032021-03-17 00:00:002023-01-31 15:58:55Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer
